Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis

Optimal Detection of Fetal Chromosomal Abnormalities by Massively Parallel DNA Sequencing of Cell-Free Fetal DNA from Maternal Blood

(2011) A. J. Sehnert et al.   CLINICAL CHEMISTRY

DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study

(2011) Glenn E. Palomaki et al.   GENETICS IN MEDICINE

2D DIGE analysis of maternal plasma for potential biomarkers of Down Syndrome

(2011) Wendy E Heywood et al.   Proteome Science

Overexpression of Human Apolipoprotein A-I Preserves Cognitive Function and Attenuates Neuroinflammation and Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer Disease

(2010) Terry L. Lewis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitative Proteomics Analysis of Maternal Plasma in Down Syndrome Pregnancies Using Isobaric Tagging Reagent (iTRAQ)

(2010) Varaprasad Kolla et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Sensitivity of Noninvasive Prenatal Detection of Fetal Aneuploidy from Maternal Plasma Using Shotgun Sequencing Is Limited Only by Counting Statistics

(2010) H. Christina Fan et al.   PLoS One

The Fibronectin RGD Motif Is Required for Multiple Angiogenic Events During Early Embryonic Development

(2009) Seiichiro Takahashi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Common Coding Variants of the HNF1A Gene Are Associated With Multiple Cardiovascular Risk Phenotypes in Community-Based Samples of Younger and Older European-American Adults

(2009) Alexander P. Reiner et al.   Circulation-Cardiovascular Genetics

Intrinsic defect of the immune system in children with Down syndrome: a review

(2009) M. A. A. Kusters et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Discovery of Novel Serum Biomarkers for Prenatal Down Syndrome Screening by Integrative Data Mining

(2009) Jeroen L. A. Pennings et al.   PLoS One

Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening

(2009) M. P. H. Koster et al.   PRENATAL DIAGNOSIS

Current Methods of Prenatal Screening for Down Syndrome and Other Fetal Abnormalities

(2008) DEVEREUX N. SALLER et al.   CLINICAL OBSTETRICS AND GYNECOLOGY

Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes

(2008) Tzu-Hao Wang et al.   FERTILITY AND STERILITY

Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down Syndrome

(2008) V. P. Prasher et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

iTRAQ Experimental Design for Plasma Biomarker Discovery

(2008) Xiaomin Song et al.   JOURNAL OF PROTEOME RESEARCH

Increase in Incidence of Medically Treated Thyroid Disease in Children With Down Syndrome After Rerelease of American Academy of Pediatrics Health Supervision Guidelines

(2008) K. N. Carroll et al.   PEDIATRICS

Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma

(2008) Aggeliki Kolialexi et al.   PRENATAL DIAGNOSIS